Literature DB >> 27704282

Climbing fiber-Purkinje cell synaptic pathology in tremor and cerebellar degenerative diseases.

Sheng-Han Kuo1, Chi-Ying Lin2,3, Jie Wang2,4, Peter A Sims5, Ming-Kai Pan2,6, Jyun-You Liou7, Danielle Lee2, William J Tate8, Geoffrey C Kelly8, Elan D Louis9,10, Phyllis L Faust8.   

Abstract

Changes in climbing fiber-Purkinje cell (CF-PC) synaptic connections have been found in the essential tremor (ET) cerebellum, and these changes are correlated with tremor severity. Whether these postmortem changes are specific to ET remains to be investigated. We assessed CF-PC synaptic pathology in the postmortem cerebellum across a range of degenerative movement disorders [10 Parkinson's disease (PD) cases, 10 multiple system atrophy (MSA) cases, 10 spinocerebellar ataxia type 1 (SCA1) cases, and 20 ET cases] and 25 controls. We observed differences in terms of CF pathological features across these disorders. Specifically, PD cases and ET cases both had more CFs extending into the parallel fiber (PF) territory, but ET cases had more complex branching and increased length of CFs in the PF territory along with decreased CF synaptic density compared to PD cases. MSA cases and SCA1 cases had the most severely reduced CF synaptic density and a marked paucity of CFs extending into the PF territory. Furthermore, CFs in a subset of MSA cases formed collateral branches parallel to the PC layer, a feature not seen in other diagnostic groups. Using unsupervised cluster analysis, the cases and controls could all be categorized into four clusters based on the CF pathology and features of PC pathology, including counts of PCs and their axonal torpedoes. ET cases and PD cases co-segregated into two clusters, whereas SCA1 cases and MSA cases formed another cluster, separate from the control cluster. Interestingly, the presence of resting tremor seemed to be the clinical feature that separated the cases into the two ET-PD clusters. In conclusion, our study demonstrates that these degenerative movement disorders seem to differ with respect to the pattern of CF synaptic pathology they exhibit. It remains to be determined how these differences contribute to the clinical presentations of these diseases.

Entities:  

Keywords:  Climbing fiber; Essential tremor; Multiple system atrophy; Parkinson’s disease; Purkinje cell; Spinocerebellar ataxia

Mesh:

Substances:

Year:  2016        PMID: 27704282      PMCID: PMC5481163          DOI: 10.1007/s00401-016-1626-1

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  58 in total

1.  Oscillating Purkinje neuron activity causing involuntary eye movement in a mutant mouse deficient in the glutamate receptor delta2 subunit.

Authors:  Takashi Yoshida; Akira Katoh; Gen Ohtsuki; Masayoshi Mishina; Tomoo Hirano
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

2.  NeuriteTracer: a novel ImageJ plugin for automated quantification of neurite outgrowth.

Authors:  Madeline Pool; Joachim Thiemann; Amit Bar-Or; Alyson E Fournier
Journal:  J Neurosci Methods       Date:  2007-09-08       Impact factor: 2.390

Review 3.  Long-term depression as a model of cerebellar plasticity.

Authors:  Masao Ito; Kazuhiko Yamaguchi; Soichi Nagao; Tadashi Yamazaki
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

4.  Somatosensory receptive fields of single units in cat cerebellar cortex.

Authors:  W T Thach
Journal:  J Neurophysiol       Date:  1967-07       Impact factor: 2.714

5.  Abnormalities in the climbing fiber-Purkinje cell circuitry contribute to neuronal dysfunction in ATXN1[82Q] mice.

Authors:  Justin A Barnes; Blake A Ebner; Lisa A Duvick; Wangcai Gao; Gang Chen; Harry T Orr; Timothy J Ebner
Journal:  J Neurosci       Date:  2011-09-07       Impact factor: 6.167

Review 6.  Essential tremors: a family of neurodegenerative disorders?

Authors:  Elan D Louis
Journal:  Arch Neurol       Date:  2009-10

7.  Deep brain stimulation and climbing fiber synaptic pathology in essential tremor.

Authors:  Sheng-Han Kuo; Chi-Ying Lin; Jie Wang; Jyun-You Liou; Ming-Kai Pan; Ravi J Louis; Wei-Pu Wu; Jesus Gutierrez; Elan D Louis; Phyllis L Faust
Journal:  Ann Neurol       Date:  2016-08-02       Impact factor: 10.422

8.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

Review 9.  Structural plasticity of climbing fibers and the growth-associated protein GAP-43.

Authors:  Giorgio Grasselli; Piergiorgio Strata
Journal:  Front Neural Circuits       Date:  2013-02-21       Impact factor: 3.492

10.  Patterns of regional cerebellar atrophy in genetic frontotemporal dementia.

Authors:  Martina Bocchetta; M Jorge Cardoso; David M Cash; Sebastien Ourselin; Jason D Warren; Jonathan D Rohrer
Journal:  Neuroimage Clin       Date:  2016-02-21       Impact factor: 4.881

View more
  32 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

Review 2.  Current Opinions and Consensus for Studying Tremor in Animal Models.

Authors:  Sheng-Han Kuo; Elan D Louis; Phyllis L Faust; Adrian Handforth; Su-Youne Chang; Billur Avlar; Eric J Lang; Ming-Kai Pan; Lauren N Miterko; Amanda M Brown; Roy V Sillitoe; Collin J Anderson; Stefan M Pulst; Martin J Gallagher; Kyle A Lyman; Dane M Chetkovich; Lorraine N Clark; Murni Tio; Eng-King Tan; Rodger J Elble
Journal:  Cerebellum       Date:  2019-12       Impact factor: 3.847

3.  Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor.

Authors:  Ruo-Yah Lai; Darya Tomishon; Karla P Figueroa; Stefan M Pulst; Susan Perlman; George Wilmot; Christopher M Gomez; Jeremy D Schmahmann; Henry Paulson; Vikram G Shakkottai; Sarah H Ying; Theresa Zesiewicz; Khalaf Bushara; Michael Geschwind; Guangbin Xia; S H Subramony; Tetsuo Ashizawa; Sheng-Han Kuo
Journal:  Cerebellum       Date:  2019-06       Impact factor: 3.847

4.  Contextualizing the pathology in the essential tremor cerebellar cortex: a patholog-omics approach.

Authors:  Elan D Louis; Chloë A Kerridge; Debotri Chatterjee; Regina T Martuscello; Daniel Trujillo Diaz; Arnulf H Koeppen; Sheng-Han Kuo; Jean-Paul G Vonsattel; Peter A Sims; Phyllis L Faust
Journal:  Acta Neuropathol       Date:  2019-07-17       Impact factor: 17.088

Review 5.  Molecular Mechanisms and Therapeutics for Spinocerebellar Ataxia Type 2.

Authors:  Polina A Egorova; Ilya B Bezprozvanny
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

6.  Early stage glioblastoma: retrospective multicentric analysis of clinical and radiological features.

Authors:  Isabella Ceravolo; Giovanni Barchetti; Francesco Biraschi; Carmela Gerace; Enrico Pampana; Alberto Pingi; Alessandro Stasolla
Journal:  Radiol Med       Date:  2021-08-02       Impact factor: 3.469

7.  Climbing fiber-Purkinje cell synaptic pathology across essential tremor subtypes.

Authors:  Danielle Lee; Shi-Rui Gan; Phyllis L Faust; Elan D Louis; Sheng-Han Kuo
Journal:  Parkinsonism Relat Disord       Date:  2018-02-20       Impact factor: 4.891

8.  Cerebellar Volume Is Associated with Cognitive Decline in Mild Cognitive Impairment: Results from ADNI.

Authors:  Chi-Ying Lin; Chi-Hua Chen; Sarah E Tom; Sheng-Han Kuo
Journal:  Cerebellum       Date:  2020-04       Impact factor: 3.847

Review 9.  Role of Microglia in Ataxias.

Authors:  Austin Ferro; Carrie Sheeler; Juao-Guilherme Rosa; Marija Cvetanovic
Journal:  J Mol Biol       Date:  2019-01-18       Impact factor: 5.469

10.  Repeated Spiral Drawings in Essential Tremor: a Possible Limb-Based Measure of Motor Learning.

Authors:  Christine Y Kim; Lan Luo; Qiping Yu; Ana Mirallave; Rachel Saunders-Pullman; Richard B Lipton; Elan D Louis; Seth L Pullman
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.